Holocene Advisors, LP Horizon Therapeutics Public LTD CO Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $1.99 Million - $2.32 Million	20,661 New	20,661 $2.12 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $50.7 Million - $74.3 Million	-638,444 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $23.1 Million - $29.3 Million	-267,236 Reduced 29.51%	638,444 $67.2 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $51.7 Million - $62.9 Million	524,819 Added 137.8%	905,680 $97.6 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $32.2 Million - $38.6 Million	350,116 Added 1138.77%	380,861 $41.7 Million

Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $2.65 Million - $2.95 Million	30,745 New	30,745 $2.88 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.